IL18 and cancer: When interacting with danger associated molecules (DAMPs) derived from cancer cells, membrane components of innate immunity, such as pattern recognition receptor (PRR), trigger a response of inflammasomes, resulting in activation of caspase-1, which cleaves pro-IL18 and produces IL-18.